X-RX Trademark

Trademark Overview

On Tuesday, November 12, 2013, a trademark application was filed for X-RX with the United States Patent and Trademark Office. The USPTO has given the X-RX trademark a serial number of 86116840. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 26, 2021. This trademark is owned by X-Rx, Inc.. The X-RX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; product research and development in the fields of pharmaceuticals and biotechnology
x-rx

General Information

Serial Number86116840
Word MarkX-RX
Filing DateTuesday, November 12, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 26, 2021
Registration Number4700882
Registration DateTuesday, March 10, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2014

Trademark Statements

Goods and ServicesDrug discovery services; product research and development in the fields of pharmaceuticals and biotechnology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 26, 2021
Primary Code042
First Use Anywhere DateTuesday, December 31, 2013
First Use In Commerce DateTuesday, December 31, 2013

Trademark Owner History

Party NameX-Rx, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameX-Rx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453
Party NameX-Rx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events

Event DateEvent Description
Friday, November 26, 2021CANCELLED SEC. 8 (6-YR)
Tuesday, March 10, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, January 27, 2020REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Monday, January 27, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, May 31, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 31, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 10, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, February 4, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 3, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 29, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 2, 2014USE AMENDMENT FILED
Monday, January 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 2, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, June 3, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 8, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 8, 2014PUBLISHED FOR OPPOSITION
Wednesday, March 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 27, 2014ASSIGNED TO EXAMINER
Monday, November 25, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 15, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

fields pharmaceuticals biotechnology development research discovery services product drug